VEGFA and medullary thyroid gland carcinoma: To address this, we investigated the anticancer effects of Sorafenib on MTC, both as a standalone treatment and in combination with the VEGF inhibitor Bevacizumab, with the goal of reducing the dosage and minimizing the side effects of tyrosine kinase inhibitors.